FFaulkner
TL3 Regular · Ljubljana, SI
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 10 October 2024 · last posted 5h · groups: analytical-chemists
120 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #121 · Analytics › Impurities & related substances · 28 Jul 2026 · 2 likes post #120 is right about the mechanism and I think understates the practical bit. Residual solvents: traces of solvents used in purification. These are usually tested…
-
Spreadsheets: an appreciation — what changed since Replied, post #114 · Lounge › Off topic · 27 Jul 2026 · 23 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #19 · Compounds › Tirzepatide · 26 Jul 2026 · 14 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Designing a personal experiment that could change your mind — one year on Replied, post #77 · Research Methods › N-of-1 designs · 18 Jul 2026 · 17 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #107 · Evidence › Journal club · 15 Jul 2026 · 4 likes post #106 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed…
-
Insurance and replacement policies, compared Replied, post #87 · Sourcing › Logistics · 14 Jul 2026 · 3 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #38 · Practice › Side effects · 9 Jul 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
How much context is too much context in a first post? Replied, post #14 · Start Here › How to Ask · 5 Jul 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Asking a follow-up: new topic or new reply? Replied, post #38 · Start Here › How to Ask · 5 Jul 2026 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #53 · Access › International · 3 Jul 2026 · 33 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #3 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #16 · Nutrition & Training › Protein & intake · 29 Jun 2026 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Insurance and replacement policies, compared Replied, post #43 · Sourcing › Logistics · 26 Jun 2026 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Journal club: LEADER as the historical anchor Replied, post #94 · Evidence › Journal club · 24 Jun 2026 · 5 likes I read post #92 twice before replying, because I had assumed the opposite. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Started this topic · Compounds › Repair & healing peptides · 24 Jun 2026 · 28 likes Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #6 · Nutrition & Training › Protein & intake · 24 Jun 2026 · 0 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #36 · Access › Insurance & coverage · 24 Jun 2026 · 6 likes On post #32 — agreed on the reasoning, with one qualification. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #94 · Evidence › Journal club · 22 Jun 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #38 · Evidence › Journal club · 16 Jun 2026 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. Session format: read the paper before posting. The discussion is much better when…
-
Injecting into an area that has become firm: why not to Replied, post #30 · Practice › Administration · 7 Jun 2026 · 1 like Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #5 · Outcomes › Body composition · 3 Jun 2026 · 8 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #31 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 18 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Documenting a supplier's response to a discrepancy Replied, post #4 · Sourcing › Vendor reports · 27 May 2026 · 5 likes Worth separating two things that the opening post runs together. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #32 · Practice › Administration · 25 May 2026 · 1 like post #31 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: A structured critique template this community uses Replied, post #15 · Evidence › Study critique · 20 May 2026 · 13 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #23 · Research Methods › Statistics · 13 May 2026 · 24 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #10 · Documentation › Doc review · 9 May 2026 · 3 likes post #9 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #52 · Compounds › Semaglutide · 8 May 2026 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #9 · Analytics › Mass spectrometry · 2 May 2026 · 3 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #17 · Evidence › Study critique · 25 Apr 2026 · 1 like Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #3 · Analytics › Method validation · 21 Apr 2026 · 8 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
How to ask about something you suspect is a bad idea Replied, post #76 · Start Here › How to Ask · 13 Apr 2026 · 2 likes Worth separating two things that post #72 runs together. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #6 · Analytics › Method validation · 11 Apr 2026 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #72 · Practice › Administration · 7 Apr 2026 · 7 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Spike-and-recover accuracy for a peptide assay Replied, post #13 · Analytics › Method validation · 7 Apr 2026 · 5 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
A site rotation scheme that is easy enough to actually follow Replied, post #30 · Practice › Administration · 30 Mar 2026 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: The storage lookup and where its data comes from Started this topic · Data & Tools › Calculators · 26 Mar 2026 · 56 likes On the subject in the title: Second pass at: The storage lookup and where its data comes from Working notes rather than a conclusion. A documentation question rather…
-
Managing an unplanned gap in supply Replied, post #55 · Access › Shortages · 9 Mar 2026 · 8 likes Picking up post #52: that is the part I would want checked first. Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #147 · Analytics › COA interpretation · 7 Mar 2026 · 1 like When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #61 · Practice › Interactions · 3 Mar 2026 · 2 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #116 · Practice › Interactions · 20 Feb 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
MHRA statements, read directly Replied, post #90 · Regional › UK & Ireland · 16 Feb 2026 · 2 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #60 · Outcomes › Progress reports · 15 Feb 2026 · 2 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Reading an interaction checker output critically Replied, post #109 · Practice › Interactions · 3 Feb 2026 · 30 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #10 · Clinical › Bloodwork · 28 Jan 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #15 · Evidence › Trials · 26 Jan 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Oral semaglutide bioavailability and its variability between people Replied, post #29 · Compounds › Oral incretins · 20 Jan 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Angle of injection and whether 90 degrees is always right Replied, post #77 · Practice › Administration · 5 Jan 2026 · 29 likes On post #73 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #94 · Practice › Side effects · 29 Dec 2025 · 25 likes post #93 is right about the mechanism and I think understates the practical bit. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain,…
-
Reading SURMOUNT-1 without the press release Replied, post #110 · Compounds › Tirzepatide · 22 Dec 2025 · 9 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
DXA precision and the least significant change for lean mass Replied, post #77 · Outcomes › Body composition · 17 Dec 2025 · 26 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Tracking a preprint to publication: a worked example Replied, post #44 · Evidence › Preprints · 4 Dec 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #17 · Safety › Contraindications · 3 Dec 2025 · 22 likes post #16 is right about the mechanism and I think understates the practical bit. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric…
-
The headache that turns out to be dehydration Replied, post #74 · Nutrition & Training › Hydration & electrolytes · 28 Nov 2025 · 1 like On post #70 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #47 · Compounds › Other compounds · 24 Nov 2025 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Lurking for two months before posting: was that the right call? Replied, post #42 · Start Here › Welcome · 19 Nov 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Long-time reader, first-time poster Replied, post #18 · Lounge › Introductions · 16 Nov 2025 · 17 likes Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is fine.
-
Documentation that materially improves an appeal's chances Replied, post #65 · Access › Insurance & coverage · 15 Nov 2025 · 20 likes Coming back to post #63, because the follow-up matters more than the original answer. Formulary status: the list of covered medications and the tier (how much you pay)…
-
Second pass at: The mass-error checker and its intended scope Replied, post #64 · Data & Tools › Calculators · 15 Nov 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #43 · Compounds › Oral incretins · 14 Nov 2025 · 0 likes Worth separating two things that post #39 runs together. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #37 · Analytics › Method validation · 4 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #20 · Analytics › Method validation · 19 Oct 2025 · 0 likes post #19 answers the question as asked. The question underneath it is different. Stability-indicating method: one that can separate a compound from its degradation…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #26 · Analytics › Method validation · 18 Oct 2025 · 2 likes post #25 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Reading a supplier's product description as a marketing document Replied, post #84 · Compounds › Other compounds · 15 Oct 2025 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
The headache that turns out to be dehydration Replied, post #23 · Nutrition & Training › Hydration & electrolytes · 14 Oct 2025 · 0 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Managing an unplanned gap in supply — what changed since Replied, post #84 · Access › Shortages · 10 Oct 2025 · 31 likes On post #80 — agreed on the reasoning, with one qualification. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Started this topic · Compounds › Tirzepatide · 9 Oct 2025 · 28 likes Posting this under the heading it deserves: The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Everything below is what sits…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 33 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Sleep quality changes during weight loss — what changed since Replied, post #6 · Wellbeing › Sleep · 22 Sep 2025 · 21 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #2 · Practice › Side effects · 17 Sep 2025 · 19 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #56 · Practice › Storage & stability · 13 Sep 2025 · 0 likes This follows post #53 rather than contradicting it. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #15 · Evidence › Study critique · 12 Sep 2025 · 29 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #108 · Data & Tools › Datasets · 10 Sep 2025 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #79 · Evidence › Journal club · 5 Sep 2025 · 0 likes Worth separating two things that post #75 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #8 · Documentation › Doc review · 28 Aug 2025 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Immortal time bias in a claims-database study Replied, post #29 · Evidence › Study critique · 24 Aug 2025 · 22 likes Coming back to post #27, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #21 · Access › Pricing · 9 Aug 2025 · 24 likes Coming back to post #19, because the follow-up matters more than the original answer. Biosimilars and future generics: as patents expire, biosimilar and generic…
-
Repeatability versus intermediate precision Replied, post #59 · Analytics › Method validation · 25 Jun 2025 · 11 likes This follows post #56 rather than contradicting it. System suitability: injections run at the start of a batch to establish that the instrument and column are…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #16 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 0 likes Worth separating two things that post #12 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Triple agonism: additive, synergistic, or neither? Replied, post #60 · Compounds › Retatrutide · 24 Jun 2025 · 4 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #10 · Analytics › Method validation · 17 Jun 2025 · 3 likes post #9 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Washout: how long is long enough, and for what purpose Replied, post #36 · Pharmacology › Pharmacokinetics · 16 Jun 2025 · 18 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Temperature loggers worth the money Replied, post #2 · Devices › Cold chain · 16 Jun 2025 · 6 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #101 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 16 likes post #100 answers the question as asked. The question underneath it is different. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #15 · Access › Insurance & coverage · 14 Jun 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Asking about a compound your prescriber has not heard of Replied, post #63 · Clinical › Prescriber conversations · 11 Jun 2025 · 3 likes Coming back to post #61, because the follow-up matters more than the original answer. Preparing for an appointment: bring recent bloodwork, a list of current…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #2 · Evidence › Meta-analyses · 10 Jun 2025 · 1 like Picking up the opening post: that is the part I would want checked first. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #5 · Compounds › Secretagogues & GH axis · 8 May 2025 · 14 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #146 · Sourcing › Regulatory · 7 May 2025 · 8 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Charge states for a 4 kDa peptide, worked through Replied, post #128 · Analytics › Mass spectrometry · 16 Mar 2025 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #30 · Sourcing › Vendor reports · 15 Mar 2025 · 4 likes This follows post #27 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #33 · Clinical › Comorbidities · 14 Mar 2025 · 14 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Charge states for a 4 kDa peptide, worked through Replied, post #44 · Analytics › Mass spectrometry · 7 Mar 2025 · 0 likes Worth separating two things that post #40 runs together. Resolution: "high resolution" commonly means
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #39 · Documentation › Doc review · 28 Feb 2025 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #25 · Compounds › Other compounds · 24 Feb 2025 · 15 likes Worth separating two things that post #21 runs together. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #18 · Compounds › Other compounds · 2 Feb 2025 · 15 likes Coming back to post #16, because the follow-up matters more than the original answer. Compounds this community declines to help with, and why: there are specifics in…
-
What changed in 2026, by region Replied, post #81 · Access › International · 16 Jan 2025 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #11 · Access › Pricing · 6 Jan 2025 · 23 likes Worth separating two things that post #7 runs together. Subscription services and subscriptions: some online clinics bundle compounds into subscription models with…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #21 · Evidence › Journal club · 3 Jan 2025 · 5 likes Worth separating two things that post #17 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #80 · Evidence › Journal club · 3 Jan 2025 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #137 · Practice › Dosing & titration · 30 Dec 2024 · 4 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #51 · Compounds › Oral incretins · 26 Dec 2024 · 21 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #41 · Compounds › Semaglutide · 26 Dec 2024 · 19 likes post #40 answers the question as asked. The question underneath it is different. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #99 · Compounds › Tirzepatide · 20 Dec 2024 · 28 likes post #98 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Converting between mg/mL and units per dose, both directions Replied, post #137 · Practice › Reconstitution · 19 Dec 2024 · 1 like Picking up post #134: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #22 · Analytics › Mass spectrometry · 19 Dec 2024 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #83 · Analytics › Method validation · 16 Dec 2024 · 29 likes Worth separating two things that post #79 runs together. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #62 · Analytics › Method validation · 12 Dec 2024 · 24 likes post #61 answers the question as asked. The question underneath it is different. Forced degradation studies: deliberately stress the material with acid, base, oxidant,…
-
Body image changing more slowly than the body Replied, post #8 · Wellbeing › Mental health · 10 Dec 2024 · 0 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
What would change my mind about repair peptides: a specific answer — one year on Replied, post #3 · Compounds › Repair & healing peptides · 22 Oct 2024 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #31 · Wellbeing › Mental health · 14 Oct 2024 · 6 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #22 · Practice › Administration · 11 Sep 2024 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Correlation in a self-tracked dataset: what it can support Replied, post #153 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #16 · Sourcing › Independent verification · 25 Aug 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #15 · Compounds › Semaglutide · 21 Aug 2024 · 10 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #44 · Analytics › Mass spectrometry · 19 Aug 2024 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Chronic kidney disease and the FLOW result Replied, post #3 · marked as the solution · Clinical › Comorbidities · 9 Aug 2024 · 23 likes This follows post #2 rather than contradicting it. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was…
-
Request: a diff view for wiki revisions Replied, post #3 · Meta › Feature requests · 29 Jul 2024 · 0 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
What happens when a maintainer goes quiet Replied, post #8 · Documentation › Doc review · 21 Jun 2024 · 6 likes post #7 is right about the mechanism and I think understates the practical bit. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the…
-
The mass-error checker and its intended scope Replied, post #15 · Data & Tools › Calculators · 27 May 2024 · 0 likes post #14 answers the question as asked. The question underneath it is different. Storage lookup: which conditions (temperature, time) are you considering storing in,…